Clinical trials
Phase 2 Purpura, Thrombocytopenic, Idiopathic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2013 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 6 |
| Recruiting | 3 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Weill Medical College of Cornell University | 3 |
| Eisai Inc. | 2 |
| GlaxoSmithKline | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Shionogi | 2 |
| Amgen | 1 |
| Bioverativ, a Sanofi company | 1 |
| Grifols Therapeutics LLC | 1 |
| Hematology and Oncology Specialists | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 32 |
| Thrombocytopenia | 6 |
| Hematologic Diseases | 5 |
| Anemia, Hemolytic, Autoimmune | 3 |
| Blood Platelet Disorders | 3 |
| Autoimmune Diseases | 2 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Graft vs Host Disease | 2 |
| Purpura, Thrombocytopenic | 2 |
| Purpura, Thrombotic Thrombocytopenic | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.